Share
Endocrine Society experts develop new approach to benefit users of different devices Endocrine Society experts have expanded their efforts to develop streamlined methods for continuous glucose monitor (CGM) users to better manage their blood sugar levels. A panel of diabetes experts created a method for users of Abbott FreeStyle Libre CGM systems, which are among...
Share
What’s Happening in Washington Election Results – While Republicans held onto the majority in the US Senate, Democrats picked up more than the 23 seats needed to gain control of the House of Representatives when the 116th Congress convenes in January. The Democrats’ win of the House will portend serious changes in Washington, as the...
Share
As devices become smarter and smarter and improve patient outcomes, they also pose challenges for patient and clinician education. While clinicians ensure all patients are up-to-speed on the new technology, a new threat looms: Keeping data safe. In an early episode of the CBS crime drama Elementary, a man is found dead of an apparent...
Share
Treatment with empagliflozin may positively impact life expectancy in adults with type 2 diabetes and established cardiovascular disease, according to results from the EMPA-REG OUTCOME trial recently published in Circulation. Using actuarial methods and assuming that the demonstrated beneficial effects of empagliflozin remain consistent with long-term use, empagliflozin was estimated to extend life expectancy by one...
Share
When children are first diagnosed with type 1 diabetes, there are myriad challenges for the patient and the parents. A new educational program developed by Phoenix Children’s Hospital called Our Journey in the Hospital has proven to be an effective tool for the patients, parents, and clinical team. About 12 years ago at Phoenix Children’s...
Share
The Endocrine Society is calling for nominations for the 12th annual Award for Excellence in Science and Medical Journalism. The award recognizes outstanding reporting that enhances public understanding of health issues pertaining to the field of endocrinology. Endocrinologists are physicians and scientists who untangle complex symptoms to diagnose, treat, research, or cure hormone-related conditions. These...
Share
The Phase 3 PANORAMA trial evaluating aflibercept injection in patients with moderately severe and severe non-proliferative diabetic retinopathy (NPDR) met its one-year (52-week) primary endpoint and key secondary endpoints, the drug’s manufacturer announced today. Regeneron Pharmaceuticals is marketing the drug as EYELA. On the primary endpoint at one year, 80% and 65% of patients receiving...
Share
A review recently published in The Journal of Clinical Endocrinology & Metabolism looks at how genome-wide association studies (GWASs) have impacted the medical community’s understanding of the underlying biology of human growth. The paper, by Michael H. Guo, of the Broad Institute of MIT and Harvard in Cambridge, Mass., et al., summarizes key findings of...
